Connie L. Sivinski, Ph.D. - Publications
Affiliations: | 2001 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
Immunology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2002 | VanLith ML, Kohlgraf KG, Sivinski CL, Tempero RM, Hollingsworth MA. MUC1-specific anti-tumor responses: molecular requirements for CD4-mediated responses. International Immunology. 14: 873-82. PMID 12147624 DOI: 10.1093/Intimm/Dxf053 | 0.522 | |||
2002 | Sivinski CL, Kohlgraf KG, VanLith ML, Morikane K, Tempero RM, Hollingsworth MA. Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 51: 327-40. PMID 12111121 DOI: 10.1007/S00262-002-0277-3 | 0.523 | |||
2001 | Morikane K, Tempero R, Sivinski CL, Kitajima S, Gendler SJ, Hollingsworth MA. Influence of organ site and tumor cell type on MUC1-specific tumor immunity. International Immunology. 13: 233-40. PMID 11157856 DOI: 10.1093/Intimm/13.2.233 | 0.761 | |||
1999 | Morikane K, Tempero RM, Sivinski CL, Nomoto M, Van Lith ML, Muto T, Hollingsworth MA. Organ-specific pancreatic tumor growth properties and tumor immunity. Cancer Immunology, Immunotherapy : Cii. 47: 287-96. PMID 10022473 DOI: 10.1007/S002620050533 | 0.773 | |||
1995 | Sivinski CL, Lindner DJ, Borden EC, Tempero MA. Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 18: 156-65. PMID 8770771 | 0.496 | |||
1995 | Tempero MA, Haga Y, Sivinski C, Birt D, Klassen L, Thiele G. Immunologic Effects of Levamisole in Mice and Humans Journal of Immunotherapy. 17: 47-57. DOI: 10.1097/00002371-199501000-00006 | 0.434 | |||
Show low-probability matches. |